期刊文献+

卡维地罗治疗老年原发性高血压的疗效观察

The Effect of Carvedilol in Essential Hypertension Elderly
下载PDF
导出
摘要 目的:探讨卡维地罗治疗老年性高血压的安全性和有效性。方法:随机选择89例老年原发性高血压患者,服用卡维地罗(12.5 -50mg/d),测定临床血压值。结果:服药8周后有效率达83.7%(72/86),收缩压治疗前164.3±21.1mmHg降到治疗后142.4± 16.4mm Hg,舒张压治疗前105.8±12.5 mmHg降到治疗后91.2±8.7 mmHg;心率由治疗前的71.5±6.1次/min到治疗后63.7± 5.6次/min。有3例患者因心动过缓和心悸不适不能耐受而停药,无严重不良反应。结论:卡维地罗治疗老年原发性高血压有较好的疗效和安全性、临床耐受性好。 Objective: To investigate the antihypertensive effect, safety and tolerability of carvedilol on older patients with hypertension, Methods:This is a randomized, open and dose-titration study. With Carvedilol an option to increase the dose from 12.5 nag to 50mg daily after 8 weeks and followed by an open 3-month active treatment period. Blood pressure in observation was made during the period and at the end of the active treatment period. Results: After 12 weeks of administration, blood pressure and the heart rate (HR) declined significantly. Systolic blood pressure declined from 164.3 ± 21.1 mmHg to 142.4 ± 16.4 mm Hg,diastolic blood pressure declined from 105.8 ± 12. 5 to 91.2 ± 8.7 mm Hg (P〈0. 001) ; Heart rate declined from 71.5 ± 6. 1 bpm to 63.7 ± 5.6 bpm(P〈0. 001 ), No symptoms of adverse reaction were detected. Condusion:Carvedilol is an effective antihypertensive agent that can be used in people with essential hypertension in all age groups, Especially in the older.
出处 《中国临床医学》 北大核心 2005年第6期1142-1143,共2页 Chinese Journal of Clinical Medicine
关键词 卡维地罗 老年 高血压 Carvedilol Essential Hypertension Elderly
  • 相关文献

参考文献10

  • 1Staessen JA,Fagard R,Thijs L,et al.Randomised double-blind comparison of placebo and activet reatment for older patients with isolated systolic hypertension[J].Lancet,1997,350:757.
  • 2Joint National Committee on Prevention,Detection,Evaluation and Treatment of High Blood Pressure.The sixth report of the Joint National Committee on Prevention,Detection,Evaluation and Treatment of High Blood Pressure[J].Arch Intern Med,1997,157:2413.
  • 3MacMahon S,Rodgers A.The effect of blood pressure reduction in older patients:an overview of five randomized controlled trials in elderly hypertensives[J].Clin Exp Hypertens,1993,15:947.
  • 4Lindholm LH,Ekbom T.Antihypertentive therapy in the elderly:cardiovascular risk reduction and quality of life improvement[J].JAMA,1994,10(suppl 2):31.
  • 5Hansson L,Ionchetti A,Carruthers SG,et al.Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension:principal results of the hypertension optimal treatment(HOT) randomised trial[J].Lancet,1998,351:1755.
  • 6Guidelines Subcommittee.1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension[J].J Hypertens,1999,17:151.
  • 7Messerli FH,and Grossman E.Beta-blockers in hypertension:is carvedilol different? [J].Am J Cardiol,2004,93(9A):7B-12B.
  • 8Bakris GL,Fonseca V,Katholi RE,et al.Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension:A randomized controlled trial[J].JAMA,2004,292 (18):2227-2236.
  • 9Stroe AF,Gheorghiade M.Carvedilol:beta-blockade and beyond[J].Rev Cardiovasc Med,2004,5(Suppl 1):S18-27.
  • 10Dulin B,Abraham WT Pharmacology of carvedilol[J].Am J Cardiol,2004,93(9A):3B-6B.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部